Etodolac and Zoledronic acid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Etodolac (etodolac) and Zoledronic acid (zoledronic acid). Common drug interactions include headache among females and hypoxia among males.

The phase IV clinical study analyzes what interactions people have when they take Etodolac and Zoledronic acid. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Etodolac?

Etodolac has active ingredients of etodolac. It is often used in arthritis. eHealthMe is studying from 9,157 Etodolac users. Check the latest studies of Etodolac.

What is Zoledronic acid?

Zoledronic acid has active ingredients of zoledronic acid. eHealthMe is studying from 28,485 Zoledronic acid users. Check the latest studies of Zoledronic acid.

On Jul, 26, 2026

38 people who take Etodolac and Zoledronic acid together, and have interactions are studied.

Etodolac and Zoledronic acid drug interactions.

What are the common drug interactions of Etodolac and Zoledronic Acid, by gender? *:

female:

Headache (pain in head)
Hypercholesterolaemia (high levels of cholesterol in the blood)
Hyperhidrosis (abnormally increased sweating)
Hypoacusis (loss of hearing)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Iron deficiency anaemia
Lower respiratory tract infection
Pruritus (severe itching of the skin)
Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas)
Skin disorder (skin disease)

male:

Hypoxia (low oxygen in tissues)
Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
Pyrexia (fever)
Altered state of consciousness (altered state of mind)
General physical health deterioration (weak health status)
Respiratory failure (inadequate gas exchange by the respiratory system)
Acute respiratory distress syndrome
Anaemia (lack of blood)
Bladder cancer
Bone marrow failure

What are the common drug interactions of Etodolac and Zoledronic Acid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Haemoglobin decreased

40-49:

n/a

50-59:

Acute respiratory distress syndrome
Dyspnoea (difficult or laboured respiration)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Heart rate increased
Respiratory rate increased (excess breathing rate/min)
Vertigo

60+:

Hypoxia (low oxygen in tissues)
Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
Pruritus (severe itching of the skin)
Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas)
Skin disorder (skin disease)
Vitamin d deficiency
Ill-defined disorder
Pulmonary embolism (blockage of the main artery of the lung)
Platelet count decreased
Arthralgia (joint pain)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 13 people, 34.21%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 26.32%
Neuropathy Peripheral (surface nerve damage): 6 people, 15.79%
Adverse Event: 6 people, 15.79%
Constipation: 6 people, 15.79%
Insomnia (sleeplessness): 6 people, 15.79%
Metastatic Pain (pain due to cancer spread): 5 people, 13.16%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 5 people, 13.16%
Abdominal Pain Upper: 5 people, 13.16%
Nausea (feeling of having an urge to vomit): 4 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Etodolac and Zoledronic acid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously